CD-ROM

Adherence in adults

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDC005 Abstract Prevention of mother to child transmission of HIV in a resources limited population of Argentina: experience of a tertiary referral center from the public health system D.M. Cecchini1, M. Martinez2, V. Astarita3, C.F. Nieto4, R. Giesolauro5, C. Rodriguez1 1Hospital Cosme Argerich, Infectious Diseases & HIV PMTCT Working Group, Buenos Aires, Argentina, 2Hospital Cosme Argerich, Neonatology Unit & HIV PMTCT Working Group, Buenos Aires, Argentina, 3Hospital Cosme Argerich, Social Services & HIV PMTCT Working Group, Buenos Aires, Argentina, 4Hospital Cosme Argerich, Laboratory Unit, Buenos Aires, Argentina, 5Hospital Cosme Argerich, Obstetric Unit & HIV PMTCT Working Group, Buenos Aires, Argentina CDC006 Abstract Pregnancy outcome in ART-treated HIV-infected women in Birnin-Kebbi, Northwestern Nigeria J. Oyetunji1, R. Hassan2, T. Ibrahim3, A. Suleiman4, M. Yeldu5 1Federal Medical Centre, Birnin-Kebbi, Department of Obstetrics and Gynaecology, Birnin-Kebbi, Nigeria, 2Federal Medical Centre, Birnin-Kebbi, Management Services, Birnin-Kebbi, Nigeria, 3Federal Medical Centre, Birnin-Kebbi, Public Health, Birnin-Kebbi, Nigeria, 4Federal Medical Centre, Birnin-Kebbi, Department of Paediatrics, Birnin-Kebbi, Nigeria, 5Federal Medical Centre, Birnin-Kebbi, Laboratory Services, Birnin-Kebbi, Nigeria CDC007 Abstract Expanding antiretroviral therapy for pregnant positive women yet in need of treatment : the Djoungolo case study A.E. Njom Nlend1, J. Mboua Bitoungui2, C. Same Ekobo3 1National Social Insurance Fund Hospital, Pediatric Unit, Yaounde, Cameroon, 2Ministry of Public Health & Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaoundé, Cameroon, 3National Social Insurance Fund Hospital, Yaoundé, Cameroon CDC008 Abstract Evaluation of a sample-sparing assay for Nevirapine (NVP) measurements as an alternative to the High-Performance Liquid Chromatography (HPLC) method K. Salado-Rasmussen1, Z. Theilgaard1, M. Chiduo2, C. Pedersen3, M. Lemnge2, J. Gerstoft1, T.L. Katzenstein1 1Rigshospitalet, Department of Infectious Diseases, Copenhagen, Denmark, 2NIMR, Tanga, Tanzania, United Republic of, 3University of Southern Denmark, Department of Infectious Diseases, Odense, Denmark CDC009 Abstract Accessing PMTCT services among pregnant mothers in Makete district, Tanzania - is the training of more health care providers and community sensitization help in PMTCT demand creation together with increasing men involvement? J.G. Kimaro1, E. Ngogo1, J. Temba2 1Makete District Council, Health, Iringa, Tanzania, United Republic of, 2Benjamin Mkapa HIV/AIDS Foundation (BMAF), Health, Dar es salaam, Tanzania, United Republic of CDC010 Abstract PMTCT activities implementation : case of Côte d'Ivoire, from ACONDA's experience A. Kouame Herve Prao1,2, N. Dakoury1, S. Toure1,3, Kouakoussui Alain, N'Dri Eric 1ACONDA-VS CI, Medical, Abidjan, Cote D'Ivoire, 2Center for Disease Control and Prevention, Health, Abidjan, Cote D'Ivoire, 3ACONDA-VS CI, Direction, Abidjan, Cote D'Ivoire CDC011 Abstract Early infant diagnosis (EID) as a tool to assess PMTCT effectiveness and challenges O. Akinwande1, A. Omoigberale2, J. Onakewhor2, H. Esene2, C. Chime1, W. Sadoh2, R. Enzama1, J. Farley3, A. Abimiku3 1Institute of Human Virology, Abuja, Nigeria, 2University of Benin Teaching Hospital, Benin, Nigeria, 3University of Maryland Institute of Human Virology, Baltimore, United States CDC012 Abstract Adherence to antiretrovirals during and after pregnancy in women attending an HIV treatment clinic in Trinidad A. Quava-Jones Medical Research Foundation, Port-of-Spain, Trinidad and Tobago CDC013 Abstract Uptake of recommended antiretroviral regimens among HIV-positive pregnant women following addition of CD4-guided PMTCT recommendations, Thailand, 2006-2007 N. Voramongkol1, T. Naiwatanakul2, N. Kullerk1, N. Punsuwan3, W. Faikratok2, S. Pattanasin2, O. Sangwanloy3, R. Lolekha2, M.S. McConnell4 1Bureau of Health Promotion, Department of Health, Ministry of Public Health, Nontaburi, Thailand, 2Thailand MOPH - U.S. CDC Collaboration, Nonthaburi, Thailand, 3Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Nontaburi, Thailand, 4Thailand MOPH - U.S. CDC Collaboration, Nonthaburi, Thailand and Centers for Disease Control and Prevention, Atlanta, GA, United States CDC014 Abstract Mother to child transmission of HIV from pregnant women who received highly active antiretroviral therapy V. Zapozozhan1, S. Posohova2, S. Shevchenko3, T. Popova3 1Odessa State Medical University, ob/gyn, Odessa, Ukraine, 2Odessa State Medical University, Perinatal Center, Odessa, Ukraine, 3Odessa Oblast Clinical Hospital, Perinatal Center, Odessa, Ukraine CDC015 Abstract Tolerance and viral dynamics after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) to delivering women and neonates for the prevention of mother-to-child transmission of HIV-1 (PMTCT): TEmAA ANRS E. Arrivé1, M.-L. Chaix2, E. Nerrienet3, S. Blanche4, C. Rouzioux2, D. Avit5, S. Kruy Leang6, G. Gray7, L. Say3, M. Nyati7, D. K. Ekouévi5, F. Dabis1, The TEmAA ANRS 12109 Study Group 1Université Victor Segalen Bordeaux 2, INSERM U897, Bordeaux, France, 2Université Paris-Descartes EA 3620, Laboratoire de virologie, Paris, France, 3Institut Pasteur du Cambodge, Laboratoire HIV/Hépatites, Phnom Penh, Cambodia, 4Hôpital Necker Enfants Malades, Service d'Immunologie et Hématologie Pédiatrique, Paris, France, 5Programme PAC-CI/ANRS, Abidjan, Cote D'Ivoire, 6Hôpital Calmette, Service de Gynécologie-Obstétrique, Phnom Penh, Cambodia, 7Perinatal HIV Research Unit, Soweto, South Africa CDC016 Abstract Evaluation of nevirapine-use & prevention of vertical transmission of HIV at Kilimanjaro Christian Medical Centre A. Grivoyannis1, O. Oneko2 1Weill Cornell Medical College, International Medicine & Infectious Diseases, New York, United States, 2Kilimanjaro Christian Medical Centre, Obstetrics & Gynecology, Moshi, Tanzania, United Republic of CDC017 Abstract Challenges in initiating HAART in pregnant women in PMTCT programs C.N. Mnyani, G. Gray, H. Struthers, S. Kekana, A. Violari, J. McIntyre Perinatal HIV Research Unit, Johannesburg, South Africa CDC018 Abstract Efficiency of the PMTC in Benin A. Clément1, A. Evelyne2, H. Bignon Spéro Marc3, I. Yasmine4, A. George5, A. Sylviane6 1PNLS, MS, Calavi, Benin, 2PNLS, MS, Cotonou, Benin, 3SSER, PNLS Littoral, Cotonou, Benin, 4Africare, Littoral, Cotonou, Benin, 5UGFM, Littoral, Cotonou, Benin, 6CIPEC, Littoral, Cotonou, Benin CDC019 Abstract Reduction in HIV transmission risk following recommendations for CD4 testing to guide selection of prevention of mother-to-child (PMTCT) regimens, Thailand, 2006-2007 T. Naiwatanakul1, N. Punsuwan2, N. Kullerk3, W. Faikratok1, R. Lolekha1, O. Sangwanloy2, S. Pattanasin1, N. Voramongkol3, M.S. McConnell1 1Thailand MOPH - U.S.CDC Collaboration, Global AIDS Program, Nonthaburi, Thailand, 2Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand, 3Bureau of Health Promotion, Department of Health, Ministry of Public Health, Nonthaburi, Thailand CDC020 Abstract Magnitude and factors predicting loss to follow up in a cohort of pregnant women initiated on ARTs for PMTCT at Mulago Hospital Kampala, Uganda S. Ononge1, J. Byamugisha2, M. Mubiru3, D. Mubiru4, Z. Namukwaya3, M. Glenn3 1Makerere College of Health Science, Obstetrics and Gynaecology, Kampala, Uganda, 2Makerere University School of Medicine, Obstetrics and Gynaecology, Kampala, Uganda, 3Makerere U-Johns Hopkins U (MU-JHU) Research Collaboration, Kampala, Uganda, 4Makerere U-Johns Hopkins U (MU-JHU) Research Collaboration, kampala, Uganda CDC021 Abstract Characteristics of a cohort of HIV-infected Italian and immigrant pregnant women in Northern Italy I. Izzo1, M.A. Forleo1, S. Casari2, M. Romano1, A. Calabresi3, E. Quiros-Roldan1, C. Sibilia3, C. Torti1, G. Carosi1 1University of Brescia, Institute of Infectious and Tropical Diseases, Brescia, Italy, 2Spedali Civili, Brescia, Italy, 3University of Brescia, Institute of Infectious and Tropical Diseases, Brescia, Italy CDC022 Abstract The pregnancy outcomes of HIV positive mothers who present late to high-risk-antenatal clinics in Jamaica K. Whyte1, R. Pierre1, M. Anderson-Allen1, E. Williams2, K. Harvey3, P. Palmer1, C. Christie1, Kingston Paediatric and Perinatal HIV/AIDS Programme (KPAIDS) Research Group 1University of the West Indies, Kingston, Jamaica, 2Ministry of Health, National Public Health Laboratory, Kingston, Jamaica, 3Ministry of Health, National HIV/AIDS Programme, Kingston, Jamaica CDC023 Abstract Baseline CD4 counts in pregnant women in rural Zimbabwe and implications for empiric HAART P. Thistle1, R. Pilon2, A. Simor3, L. Katumbe1, A. Jetha3, M. Silverman4 1Howard Hospital, Glendale, Zimbabwe, 2Public Health Agency of Canada, Ottawa, Canada, 3University of Toronto, Toronto, Canada, 4University of Toronto, Infectious Diseases, Ajax, Canada CDC024 Abstract Provision of PMTCT minimum package at time of HIV diagnosis in Lesotho leads to high uptake of more efficacious regimens and launch of mother-baby packs internationally L. Buhendwa1, B. Motaung1,2, M. Nei1, M.P. Kieffer1, M. Mohai3 1Elizabeth Glaser Pediatric AIDS Foundation, Lesotho, Maseru, Lesotho, 2UNICEF Lesotho, Maseru, Lesotho, 3Ministry of Health and Social Welfare, PMTCT, Maseru, Lesotho